Stocks and Investing
Stocks and Investing
Thu, February 29, 2024
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
[ Thu, Feb 29th 2024
] - WOPRAI
Andrew Mok Maintained (UHS) at Hold with Increased Target to $177 on, Feb 29th, 2024
Andrew Mok of UBS, Maintained "Universal Health Services, Inc." (UHS) at Hold with Increased Target from $152 to $177 on, Feb 29th, 2024.
Andrew has made no other calls on UHS in the last 4 months.
There are 3 other peers that have a rating on UHS. Out of the 3 peers that are also analyzing UHS, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Calvin Sternick of "JP Morgan" Maintained at Hold with Decreased Target to $144 on, Friday, November 17th, 2023
These are the ratings of the 2 analyists that currently disagree with Andrew
- Stephen Baxter of "Wells Fargo" Upgraded from Hold to Buy and Held Target at $177 on, Tuesday, January 2nd, 2024
- Jamie Perse of "Goldman Sachs" Upgraded from Strong Sell to Strong Buy on, Monday, December 11th, 2023
Contributing Sources